Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells ; volume:127 ; number:4 ; day:21 ; month:5 ; year:2022 ; pages:649-660 ; date:9.2022
British journal of cancer ; 127, Heft 4 (21.5.2022), 649-660, 9.2022
- Creator
-
Zhou, Guoying
Lieshout, Ruby
Tienderen, Gilles S. van
Ruiter, Valeska de
Royen, Martin E. van
Boor, Patrick P. C.
Magré, Luc
Desai, Jyaysi
Köten, Kübra
Kan, Yik Yang
Ge, Zhouhong
Campos Carrascosa, Lucia
Geuijen, Cecile
Sprengers, Dave
Laan, Luc J. W. van der
Verstegen, Monique M. A.
Kwekkeboom, Jaap
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-022-01839-x
- URN
-
urn:nbn:de:101:1-2022102603054454313581
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Guoying
- Lieshout, Ruby
- Tienderen, Gilles S. van
- Ruiter, Valeska de
- Royen, Martin E. van
- Boor, Patrick P. C.
- Magré, Luc
- Desai, Jyaysi
- Köten, Kübra
- Kan, Yik Yang
- Ge, Zhouhong
- Campos Carrascosa, Lucia
- Geuijen, Cecile
- Sprengers, Dave
- Laan, Luc J. W. van der
- Verstegen, Monique M. A.
- Kwekkeboom, Jaap
- SpringerLink (Online service)
Other Objects (12)
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
BTK: a two-faced effector in cancer and tumour suppression
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies
Study of the cytotoxicity of asiaticoside on rats and tumour cells
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Genome engineering in fallopian tube organoids - the TP53 tumour suppressor gene as target
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platform
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
BTK: a two-faced effector in cancer and tumour suppression
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies
Study of the cytotoxicity of asiaticoside on rats and tumour cells
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Genome engineering in fallopian tube organoids - the TP53 tumour suppressor gene as target
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platform
T cell-mediated cytotoxicity against patient-derived cervical cancer organoids
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
BTK: a two-faced effector in cancer and tumour suppression
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids
Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies
Study of the cytotoxicity of asiaticoside on rats and tumour cells
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Genome engineering in fallopian tube organoids - the TP53 tumour suppressor gene as target
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay